GLMD
$2.47
Galmed Pharmaceutica
$.06
2.49%
GLMD
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.41)
Revenue:  N/A
Thursday
Aug 5
7:50 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when GLMD reports earnings?
Beat
Meet
Miss

Where is GLMD's stock price going from here?
Up
Flat
Down
Stock chart of GLMD
Analysts
Summary of analysts' recommendations for GLMD
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It is focused on developing therapies for liver diseases and gallstones. Galmed Pharmaceuticals Ltd. is based in Tel Aviv, Israel.